Study title:
Schuermann-M, Engelbrecht-V, Lohmeier-K, Lenard-H-G, Wendel-U, Gaertner-J.
Department of Paediatrics, Heinrich-Heine-University, Duesseldorf, Germany.
Cerebral metabolic changes in biotinidase deficiency.
Journal of inherited metabolic disease, {J-Inherit-Metab-Dis}, Nov 1997, vol. 20, no. 6, p. 755-60, ISSN: 0141-8955.Schuermann-M, Engelbrecht-V, Lohmeier-K, Lenard-H-G, Wendel-U, Gaertner-J.
Department of Paediatrics, Heinrich-Heine-University, Duesseldorf, Germany.
Cerebral metabolic changes in biotinidase deficiency.
Journal of inherited metabolic disease, {J-Inherit-Metab-Dis}, Nov 1997, vol. 20, no. 6, p. 755-60, ISSN: 0141-8955.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nutritional and Metabolic Diseases [C18]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: BIOTIN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|